The near-patient molecular solutions market is expected to grow at an impressive 8% CAGR during the forecast period. According to FMI, the market will be worth US$ 7.56 billion by 2033, up from US$ 3.5 billion in 2023.
Smart apps, wearable technology, and biosensors are some of the emerging technologies in the healthcare industry that are easily linked to patients’ overall health. During the forecast period, these advanced technologies will drive up demand for near-patient molecular solutions.
Point of care testing has extensive application base that includes, oncology, hematology, endocrinology, prenatal testing and near patient testing in infectious disease management. Most substantial progress have taken place in the fields of oncology point of care molecular tests and infectious diseases. Rapid flu testing is a leading application for point of care platforms.
Near-Patient Molecular Solutions Market: Drivers and Restraints
Factors, such as the increasing incidences of diseases such as cardiac diseases and diabetes in developing countries, increase in the usage of home-based point of care devices, and advancement in technology with demand for development of faster and easy to use devices are energizing the point of care diagnostic market.
For more insights into the market, request a sample of this report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2098
Rising demand for home healthcare facility and the increment in population of elderly patients with multiple chronic conditions is expected to drive point of care diagnostics market over the forecast period. In light of the many factors increasing the demand for point of care diagnosis, manufacturing companies are pushing the envelope to make point of care devices faster, easier, and more reliable. Shortage of skilled-staff, especially in the field of diagnostics, are expected to restrain the market growth for point of care diagnostic.
Near-Patient Molecular Solutions Market: Overview
Although the market of near patient diagnostic is less, but it is expected to grow over forecast period according to new healthcare analysis. It has been observed that near patient molecular solutions have witnessed higher penetration in medical system market though they facilitate better antimicrobial treatment.
Point of care products for diagnosis of tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis, malaria and other infectious diseases are supposed to achieve substantial growth in emerging markets. Manycompanies are developing molecular diagnostic platforms and assays that are designed to for near-patient. The initial focus of most of the medical devices companies is on infectious disease testing.
Near-Patient Molecular Solutions Market: Regional Overview
Region wise, the global near patient molecular solution market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominated the global market for near patient molecular solution due to good reimbursement policies for diagnostic procedures and number of clinical studies investigating the efficiency.
After North America this market is followed by Europe due to increase demand for near patient testing growth over. Asia Pacific region is expected to perceive a significantly faster growth over the forecast period due to a lower availability of hi-tech central laboratory testing facilities.Increasing number of local players providing near patient testing in countries such as China is expected to boost the market growth in APEJ region.
Near-Patient Molecular Solutions Market: Key Players
Some of the key players in the market of near patient molecular solution are Abbott Laboratories, Inc. Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., PTS Diagnostics and Nova Biomedical. Other prominent player in near patient molecular solution market are Bayer Healthcare, BioMerieux, Bio-Rad Laboratories, Cepheid, Danaher Corporation.
Ask Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-2098
The report covers exhaustive analysis on
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Near-Patient Molecular Solutions Market: Segmentation
The global near patient molecular solution market is classified on the basis of technology, product type and end user.
Based on technology, the global near patient molecular solution market is segmented into the following:
- PCR-based
- Genetic sequencing based
- Hybridization-based
- Microarray-based
Based on product type, the global near patient molecular solution market is segmented into the following:
- Infectious diseases testing kits
- Cardio metabolic monitoring kits
- Pregnancy and fertility
- Coagulation monitoring kits
- Hematology testing kits
- Urinalysis testing kits
- Glucose monitoring kits
- Drugs-of-abuse testing kits
- Testing kits
- Fecal occult testing kits
- Tumor/cancer markers
- Cholesterol test strips
- Other products
Based on end user, the global near patient molecular solution market is segmented into the following
- Hospitals
- Homecare
- Diagnostic Laboratories
- Research Laboratories
Request Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-2098
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs